Based on the AngioDynamics Inc stock forecast from 2 analysts, the average analyst target price for AngioDynamics Inc is USD 13.50 over the next 12 months. AngioDynamics Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of AngioDynamics Inc is Bearish, which is based on 1 positive signals and 6 negative signals. At the last closing, AngioDynamics Inc’s stock price was USD 8.89. AngioDynamics Inc’s stock price has changed by -1.22% over the past week, +27.91% over the past month and +14.41% over the last year.
No recent analyst target price found for AngioDynamics Inc
No recent average analyst rating found for AngioDynamics Inc
Company Overview AngioDynamics Inc
AngioDynamics, Inc., a medical technology company, engages in the design, manufacture, and sale of medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally. The company offers Auryon Atherectomy system that is designed to deliver an optimized wavelength, pulse width, and amplitude to remove lesions while preserving vessel wall endothelium. Its thrombus management portfolio includes AlphaVac mechanical thrombectomy system, an emergent mechanical aspiration device that eliminates the need for perfusionist support; thrombolytic catheters that are used to deliver thrombolytic agents, which are drugs to dissolve blood clots in hemodialysis access grafts, arteries, veins, and surgical bypass grafts; and AngioVac venous drainage cannula and extracorporeal circuit, indicated for extracorporeal circulatory support for periods of up to six hours including off-the-shelf pump, filter, and reinfusion cannula, to facilitate venous drainage as part of an extracorporeal bypass procedure. The company also offers NanoKnife IRE Ablation System, an alternative to traditional thermal ablation for the surgical ablation of soft tissue; and peripheral products, which includes angiographic catheters, and diagnostic and interventional guidewires, percutaneous drainage catheters, and coaxial micro-introducer kits used during peripheral diagnostic and interventional procedures. In addition, it provides drainage catheters for multi-purpose/general, nephrostomy, and biliary drainage; micro-Access kits provides interventional physicians a smaller introducer system for minimally invasive procedures; VenaCure EVLT system that are used in endovascular laser procedures to treat superficial venous disease; and Solero MTA System includes solero microwave generator and the specially designed solero MW applicators. The company was founded in 1988 and is headquartered in Latham, New York. Read Less
AngioDynamics, Inc., a medical technology company, engages in the design, manufacture, and sale of medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally. The compa...Read More
Frequently Asked Questions About AngioDynamics Inc (ANGO) Stock
Based on ratings from 2 analysts AngioDynamics Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Bearish. The stock has 6 buy, sell and hold ratings.
Unfortunately we do not have enough data on ANGO's stock to indicate if its a good dividend stock.
Based on targets from 2 analysts, the average taret price for ANGO is USD 13.50 over the next 12 months. The maximum analyst target price is USD 14 while the minimum anlayst target price is USD 12.
ANGO stock's Price/Earning ratio is 41.40.
Our analysis grades ANGO stock's Price / Earning ratio at F. This means that ANGO stock's Price/Earning ratio is above 63% of the stocks in the Medical Instruments & Supplies sector in the NSD exchange.
Based on this ANGO may be a overvalued for its sector.
The last closing price of ANGO's stock was USD 8.89.
The most recent market capitalization for ANGO is USD 0.37B.
Based on targets from 2 analysts, the average taret price for ANGO is projected at USD 13.50 over the next 12 months.
This means that ANGO's stock price may go up by +51.86% over the next 12 months.
We can't find any ETFs which contains AngioDynamics Inc's stock.
As per our most recent records AngioDynamics Inc has 748 Employees.
AngioDynamics Inc's registered address is 14 Plaza Drive, Latham, NY, United States, 12110.
You can get more information about it from AngioDynamics Inc's website at https://www.angiodynamics.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
High Gross Profit to Asset Ratio
This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.
What not to like
Overpriced compared to earnings
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Negative free cash flow
The company had negative total free cash flow in the most recent four quarters.
Low Revenue Growth
This stock has shown below median revenue growth in the previous 5 years compared to its sector
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Frequently Asked Questions About AngioDynamics Inc (ANGO) Stock
Based on ratings from 2 analysts AngioDynamics Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Bearish. The stock has 6 buy, sell and hold ratings.
Unfortunately we do not have enough data on ANGO's stock to indicate if its a good dividend stock.
Based on targets from 2 analysts, the average taret price for ANGO is USD 13.50 over the next 12 months. The maximum analyst target price is USD 14 while the minimum anlayst target price is USD 12.
ANGO stock's Price/Earning ratio is 41.40.
Our analysis grades ANGO stock's Price / Earning ratio at F. This means that ANGO stock's Price/Earning ratio is above 63% of the stocks in the Medical Instruments & Supplies sector in the NSD exchange.
Based on this ANGO may be a overvalued for its sector.
The last closing price of ANGO's stock was USD 8.89.
The most recent market capitalization for ANGO is USD 0.37B.
Based on targets from 2 analysts, the average taret price for ANGO is projected at USD 13.50 over the next 12 months.
This means that ANGO's stock price may go up by +51.86% over the next 12 months.
We can't find any ETFs which contains AngioDynamics Inc's stock.
As per our most recent records AngioDynamics Inc has 748 Employees.
AngioDynamics Inc's registered address is 14 Plaza Drive, Latham, NY, United States, 12110.
You can get more information about it from AngioDynamics Inc's website at https://www.angiodynamics.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for ANGO !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
